{
    "paper_id": "32c4e9713e9bc7e7e4e5aacc7c9ced949803db50",
    "metadata": {
        "title": "Supplemental Information Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses",
        "authors": [
            {
                "first": "Jincun",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jingxian",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ashutosh",
                "middle": [
                    "K"
                ],
                "last": "Mangalam",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rudragouda",
                "middle": [],
                "last": "Channappanavar",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Craig",
                "middle": [],
                "last": "Fett",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "K"
                ],
                "last": "Meyerholz",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Sudhakar",
                "middle": [],
                "last": "Agnihothram",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ralph",
                "middle": [
                    "S"
                ],
                "last": "Baric",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Chella",
                "middle": [
                    "S"
                ],
                "last": "David",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Stanley",
                "middle": [],
                "last": "Perlman",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "For systemic depletion of CD4 + or CD8 + T cells, mice were injected intraperitoneally (i.p.) with 1 mg anti-CD4 antibody (GK1.5) or 500 \uf06dg anti-CD8 antibody (2.43) at day -2 and day 0, respectively. Whole lungs were harvested at day 1 (A), or blood was harvested at indicated time points (B). Error bars represent SEM. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Cutting edge: rapid in vivo killing by 91 memory CD8 T cells",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Barber",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "J"
                    ],
                    "last": "Wherry",
                    "suffix": ""
                },
                {
                    "first": "Ahmed",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Immunol",
            "volume": "171",
            "issn": "",
            "pages": "27--31",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "CD8+ T-cell epitopes within the surface glycoprotein of a 94 neurotropic coronavirus and correlation with pathogenicity",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "Castro",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Virol",
            "volume": "69",
            "issn": "",
            "pages": "8127--8131",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in 98 transgenic mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Baisch",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Krco",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Savarirayan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hanson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hodgson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Smart",
                    "suffix": ""
                },
                {
                    "first": "David",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Eur J Immunogenet",
            "volume": "97",
            "issn": "",
            "pages": "15--20",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Antiviral CD8+ T cell effector 101 activities in situ are regulated by target cell type",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Hufford",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "S"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Braciale",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Exp Med",
            "volume": "208",
            "issn": "",
            "pages": "167--180",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "HLA-104 DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in 105 humanized transgenic mice",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Koehm",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Slavin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Hutcheson",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Trejo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "David",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bellone",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Allergy Clin Immunol",
            "volume": "120",
            "issn": "",
            "pages": "570--577",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "HLA-DRB1 polymorphism determines susceptibility to autoimmune 109 thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "C"
                    ],
                    "last": "Kong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Lomo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "W"
                    ],
                    "last": "Motte",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Giraldo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Baisch",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Strauss",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "J"
                    ],
                    "last": "Hammerling",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "David",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "J Exp 110 Med",
            "volume": "184",
            "issn": "",
            "pages": "1167--1172",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Accelerated migration of respiratory dendritic cells to the 113 regional lymph nodes is limited to the early phase of pulmonary infection",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Legge",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "J"
                    ],
                    "last": "Braciale",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Immunity",
            "volume": "18",
            "issn": "",
            "pages": "265--277",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "A mouse-adapted SARS-coronavirus causes 117 disease and mortality in BALB/c mice",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Sheahan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Heise",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "L"
                    ],
                    "last": "Genrich",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "PLoS Pathog",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Reverse genetics with a full-121 length infectious cDNA of the Middle East respiratory syndrome coronavirus",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Graham",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Swanstrom",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "F"
                    ],
                    "last": "Bove",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Proc Natl Acad",
            "volume": "122",
            "issn": "",
            "pages": "16157--16162",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Rapid generation of a 126 mouse model for Middle East respiratory syndrome",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Enjuanes",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Mccray",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Jr",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Proc Natl Acad Sci",
            "volume": "111",
            "issn": "",
            "pages": "4970--4975",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Age-related increases in PGD(2) 129 expression impair respiratory DC migration, resulting in diminished T cell responses upon 130 respiratory virus infection in mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Legge",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Clin Invest",
            "volume": "121",
            "issn": "",
            "pages": "4921--4930",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Evasion by stealth: inefficient 133 immune activation underlies poor T cell response and severe disease in SARS-CoV-infected 134 mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Van Rooijen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "PLoS Pathog",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "S1 related to Figure 1. VRP-SARS-N infected DCs presented antigen in the regional DLNs. (A) To determine DC migration from vaccinated lung or footpad to DLNs, mice were vaccinated with VRP-SARS-N i.n. or s.c. After 18 hours, single cell suspensions were prepared from MLNs or PLNs. Cells were labeled with 1:1000 diluted anti-SARS-N mouse serum, followed by Alexa488goat anti mouse IgG. The numbers represent the percentage of N + DC population (left) and total N + DC numbers per LN (right). (B) Fold increase of cell numbers in the DLNs at 18 hours post vaccination. (C) Cells from DLN were prepared at day 5 post vaccination and stimulated with N353 peptide in the presence of BFA. Cells were then stained for intracellular IFN-\uf067. IFN-\uf067 + SARS-N353-specific CD4 + T cell numbers per LN are shown. n= 3 mice/group. *P values of <0.05. Error bars represent SEM. Data are representative of 2 independent experiments.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "S2 related toFigures 1 and 5. T cell depletion. (A, B)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "S3 related to Figure 2. Recruitment from lymphoid organs and in situ proliferation contribute to protective CD4 + T responses in the respiratory tract. VRP-SARS-N i.n. vaccinated mice were treated with FTY720 (4 mg/kg) in saline i.p. daily starting one day prior to infection with 500 PFU SARS-CoV. (A) Cells from airways and lungs were stimulated with SARS-N353 peptide day 4 p.i. Numbers of IFN-\uf067 + CD4 + T cells are shown. (B) 1 mg BrdU in 100 \uf06dl PBS was delivered to FTY720 treated mice i.n. at day 4 p.i. After 4 hours, mice were sacrificed and cells from airways and lungs were stimulated with SARS-N353 peptide. Frequencies of BrdU + IFN-\uf067 + CD4 + T cells are shown. n= 3 mice/group. Error bars represent SEM. Data are representative of S4 related to Figures 3 and 5. Pro-inflammatory cytokine mRNA levels. (A, B, C) Vaccinated mice were treated with anti-CD4 antibody, IFN-\uf067 neutralizing antibody, or control antibody i.p. before SARS-CoV infection. Lungs were harvested at the indicated time points p.i. mRNA levels in the lungs were measured. n= 3-6 mice/group/time point. *P<0.05. Error bars represent SEM. Data are representative of 2 independent experiments. S5 related to Figure 2. IL-10R blockade increased mortality in SARS-CoV infected mice. (A, B) VRP-SARS-N vaccinated mice were treated with anti-CD4 antibody (GK1.5) or rIgG i.p. (A) or anti-CD4 antibody (GK1.5) or anti-IFN-\uf067 (XMG1.2) or rIgG i.n. (B). Mice were then infected with 500 PFU SARS-CoV. Lungs were harvested at indicated time points and IL-10 mRNA levels measured. n= 3-6 mice/group/time point. *P values of <0.05. Error bars represent SEM. Data are representative of 2 independent experiments. (C) For in vivo ICS, VRP-SARS-N vaccinated mice were treated with BFA i.n. or vehicle at day 6 p.i. After 6 hours, lung-derived CD4 + T cells were analyzed for IL-10 expression. IL-10 + SARS-N353-specific CD4 + T frequency is shown. Error bars represent SEM. (D) VRP-SARS-N vaccinated mice were treated i.p. with anti-IL-10R antibody (clone 1B1.3A), or equivalent doses of rIgG. Mice were infected with SARS-CoV. n= 5, rIgG i.p.; n= 10, \uf061IL-10R i.p. (E) To obtain virus titers, mice were treated with antibodies as in (D). Titers are expressed as PFU/g tissue. n= 3 mice/group/time point. Error bars represent SEM. Data are representative of 2 independent experiments. S6 related to Figure 1. Eosinophils in SARS-CoV infected lungs. 6 week-old (A) and 12 month-old (B) BALB/c mice were vaccinated with VRP-SARS-N or VRP GFP. Mice were infected with 500 PFU (A) or 100 PFU (B) SARS-CoV. At indicated time p.i., cells from lungs were prepared and stained for eosinophils (CD45 + CD11c + SiglecF + ). Most of the mice in the GFP group died by day 6. Data from days 0-4 are shown. n= 3-4 mice/group/time point. Error bars represent SEM. Data are representative of 2 independent experiments. S7 related to Figure 6. Airway-derived N350-specific CD4 + T cells are superior effector cells in MERS-CoV infected mice. Vaccinated mice were infected with MERS-CoV at the indicated times. Cells from airway and lung were stimulated with MERS-N350 peptide. Frequency (A), numbers (B) and mean fluorescence intensities (MFI) of IFN-\uf067 (C) of IFN-\uf067 + CD4 + T cells or cells expressing IFN-\uf067 and TNF, IL-10 or IL-2 (D) are shown. n= 3-4 mice/group. Error bars represent SEM. Data are representative of 3 independent experiments.Mice, virus and cells.Specific pathogen-free 6 week and 12 month old BALB/c mice were 2 purchased from the National Cancer Institute and Charles River Laboratories International.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "HLA-DR2 (DRB1*1501), HLA-DR3 (DRB1*0301) and HLA-DQ8 (DQA1*0301/DQB*0302) 4 transgenic mice were produced as previously described(Cheng et al., 1996;Koehm et al., 2007;    5Kong et al., 1996). Mice were maintained in the Animal Care Facility at the University of Iowa.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "All protocols were approved by the University of Iowa Institutional Animal Care and Use 7 Committee. The EMC/2012 strain of MERS-CoV (passage 8, designated MERS-CoV) was 8 provided by Drs. Bart Haagmans and Ron Fouchier (Erasmus Medical Center). Mouse-adapted 9 SARS-CoV (MA15) was a kind gift from Dr. Kanta Subbarao (N.I.H., Bethesda, 10 Maryland)(Roberts et al., 2007). SARS-CoV and MERS-CoV were passaged once on Vero E6 11 or Vero 81 cells and titered on the same cell line. A20 cells were used as antigen presenting 12 cells. All work with SARS-CoV and MERS-CoV was conducted in the University of Iowa",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Encephalitis Replicon particles (VRPs), recombinant vaccinia virus 16 and mouse immunization. VRPs expressing the SARS-CoV, MERS-CoV or HKU4 17 nucleocapsid proteins (N) were constructed as previously described(Scobey et al., 2013; Zhao 18 et al., 2014). Mice were primed and boosted (6-7 weeks after priming) with 1x10 5 Infectious 19 Units (IU) of VRP-SARS-N, VRP-SARS-S or VRP-GFP in the left footpad in 20 \uf06dl PBS or 20 intranasally (i.n.) in 50 \uf06dl PBS after light anesthesia with isoflurane. Recombinant vaccinia virus 21 expressing SARS-CoV N protein was generated as previously described(Castro and Perlman, 22 1995). Mice were immunized intravenously (i.v.) with 1x10 6 PFU rVV-N or irrelevant rVV in 200 23 \uf06dl PBS or i.n. in 50 \uf06dl PBS after light anesthesia with isoflurane. For sera transfer, titers. Virus was titered on Vero E6 cells or Vero 81 cells as previously described (Zhao 28 et al., 2014).29 30Histology and immunohistochemistry. Lungs were removed, fixed in zinc formalin, and 31 paraffin embedded. Sections were stained with hematoxylin and eosin for histological analysis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": ". The following anti-mouse monoclonal antibodies were used: CD4 (JEH6-5H4); IL-10 (JES-2A5); CD16/32 (2.4G2); CD11a (M17/4); CD27 (LG.7F9); CD44 (IM7); 36 CD49d (R1-2); CD69 (H1.2F3); CD103 (2E7); CD127 (eBioSB/199); Ly6C (AL-21); CXCR3 37 (CXCR3-173); CCR4 (2G12); CCR5 (HM-CCR5); CD11c (HL3); Siglec F (E50-2440); I-A/E 38 (M5/114.15.2); CCR7 (4B12); CD45 (30-F11); CD40 (HM40-3); CD80 (16-10A1); CD86 (GL1);",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "-bet (eBio4B10); CD107a (eBio1D4B); CD107b (ABL-93); Granzyme B (16G6), all antibodies 40 were from BD Bioscience, eBioscience or Biolegend.41For surface staining, 10 6 cells were blocked with 1 \uf06dg anti-CD16/32 antibody and 1% rat 42 serum, and stained with the indicated antibodies at 4 o C, except for those stained with CCR7, 43 which were stained at 37 o C.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "in vitro intracellular cytokine/protein staining, 1\u00d710 6 cells/well were cultured in 96-well 45 dishes at 37 o C for 5-6 hours in the presence of 2.5-10 \uf06dM peptide (BioSynthesis Inc., 46 Lewisville, TX), brefeldin A (BFA, BD Biosciences) and antigen presenting cells (A20 cells). Cells were then labeled for cell surface markers, fixed/permeabilized with Cytofix/Cytoperm 48 Solution (BD Biosciences) and labeled with anti-intracellular cytokine/protein antibodies.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "49To assess functional avidity, cells were stimulated with graded doses of the relevant 50 peptide pulsed onto A20 cells and examined for IFN-\uf067 production. The frequency of CD4 + T cells 51 producing IFN-\uf067 at each concentration of peptide was measured and expressed as a 52 percentage of the maximum response detected. Data were fit to sigmoidal dose-response 53 curves and used to calculate the amount of peptide needed to reach a half-maximum response 54 (EC 50 ).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "in vivo intracellular cytokine staining, infected mice were treated with 50 \uf06dg BFA 56 (Sigma-Aldrich) or vehicle (DMSO) i.n. 6 h later, lung-derived lymphocytes were analyzed 57 directly ex vivo for IFN-\uf067 or IL-10 expression as described previously(Hufford et al., 2011).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "N + rDC staining, cells from MLNs were labeled for cell surface markers, 59 fixed/permeabilized with Cytofix/Cytoperm Solution (BD Biosciences) and labeled with 1:1000 60 diluted anti-N serum, followed by A488-Goat anti mouse IgG.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "MHC class II tetramer staining, cells were stained with 8 \u03bcg/ml APC-conjugated I-A b 62 /N353 tetramers (obtained from the National Institutes of Health/National Institute of Allergy and 63 Infection Diseases MHC Tetramer Core Facility, Atlanta, GA) in complete RPMI 1640 media for 64 1 h at 37\u00b0C. Cells were then incubated with surface and intracellular markers.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "65All flow cytometry data were acquired on a BD FACSCalibur or BD FACSVerse and 66 analyzed using FlowJo software (Tree Star, Inc.).67 68In situ CFSE staining. CFSE (Molecular Probes) (8 mM) was administered i.n. (50 \uf06dl/mouse) 6 69 hours before infection(Legge and Braciale, 2003).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "cytotoxicity assay. In vivo cytotoxicity assays in the lungs were performed and 72 analyzed on day 6 p.i., as previously described(Barber et al., 2003;Zhao et al., 2009).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "chemokine RNA levels in infected lungs using qRT-PCR. RNA was extracted 75 from infected lungs using Trizol (Invitrogen), and used as a template for cDNA synthesis 76 (Invitrogen). qRT-PCR was performed using a previously described set of primers (Zhao et al.immunization and T cell proliferation assay. Mice were immunized subcutaneously 80 with N peptides (100 \uf06dg) emulsified in CFA and sacrificed 10 days later; draining lymph nodes 81 were removed and stimulated with peptides in vitro. The results are presented as stimulation 82 indices (cpm of test sample/cpm of the control).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "BrdU treatment. Vaccinated mice were treated with FTY720 (4 mg/kg) (Cayman, 85 Ann Arbor, MI) in saline i.p. daily starting one day prior to SARS-CoV infection. 1 mg BrdU (BD)86in 100 \uf06dl PBS was delivered i.n. to FTY720-treated mice at day 4 p.i., 4 hours before sacrifice.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "Intracellular detection of BrdU was performed using reagents and protocols provided by the 88 manufacturer (BD).",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}